Welcome to Myeloma News.com!

WELCOME TO MYELOMA NEWS.COM!

My name is Pat Killingsworth, and I have multiple myeloma. I am disabled now, but I still work part-time as a freelance medical writer, covering cancer related conferences and interviewing the brightest myeloma experts from around the world. I try and report on the information I gather from a patient's perspective.

HERE IS HOW IT WORKS: Each story features a short description. Below that you will find a headline. If you would like to read more, simply click-on the headline, and it will take you directly to the source. Quick and easy!

I share my opinions about these and other topics on my daily blog: www.MultipleMyelomaBlog.com.

Good luck and remember: Feel good and keep smiling! Pat

Tuesday, January 25, 2011

Geron Corporation Starts New Phase 2 Clinical Trial Of The Company's Telomerase Inhibitor, Imetelstat (GRN163L)


No comments:

Post a Comment